mbiomics GmbH
PrivateLast Round
Series A
Apr 28, 2026
Total Funding Raised
$70.2M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
mbiomics GmbH is a biotechnology company that develops live bacterial therapeutics and microbiome-based diagnostic platforms for severe and chronic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
mbiomics GmbH Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
mbiomics GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 28, 2026 | ||||
| Series A | Mar 23, 2023 |
Key People
Founding team and executive leadership
mbiomics GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MIG Capital | Series A |
| Bayern Kapital | Series A |
| High-Tech Gründerfonds | Series A |
| MIG Fonds | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 4, 2026
$35M round led by Bayern Kapital and MIG Fonds.
- Apr 29, 2026
Lead candidate MBX-116 preparing for clinical evaluation for advanced melanoma.
mbiomics GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about mbiomics GmbH's valuation, stock price, and market status.